What is Arcutis Biotherapeutics, Inc.'s long-term debt?

Arcutis Biotherapeutics, Inc. (ARQT) reported long-term debt of $101.47M in Q1 2026.

How has Arcutis Biotherapeutics, Inc.'s long-term debt changed year-over-year?

Arcutis Biotherapeutics, Inc.'s long-term debt decreased by 5.7% year-over-year, from $107.62M to $101.47M.

What does long-term debt mean?

Bonds, term loans, notes payable, and other borrowings with maturities beyond one year — the primary long-term financing source.

Arcutis Biotherapeutics, Inc. ARQT Long-Term Debt

Long-Term Debt at other companies

PfizerPFE

$60.57B+5.1%

AmgenAMGN

$51.89B-3.9%

OrganonOGN

$8.55B-4.3%

TG TherapeuticsTGTX

$745.14M+204%

Rhythm Pharmaceuticals, Inc.RYTM

$98.34M-8.9%

BridgeBio PharmaBBIO

——

Other financials

Income statement

See full

Revenue$105.4M+60.1%

Gross profit$95.6M+67.7%

Operating income-$9.1M+62.9%

Net income-$11.3M+54.9%

EPS (diluted)-$0.09+55.0%

Balance sheet

See full

Cash & equivalents$35.1M-34.7%

Total debt$114.7M+3.5%

Total equity$189.6M+32.9%

Total assets$460.0M+33.7%

Cash flow

See full

Operating cash flow$2.2M+107%

CapEx--100%

Free cash flow$2.2M+107%

Valuation

See full

Market cap$3.28B+57.5%

Enterprise value$3.36B+57.0%

P/S7.9×-1.9×

Profitability

See full

Gross margin90.9%+2.5pp

Operating margin-12%-5.7pp

Net margin-13.9%-6.6pp

FCF margin-52.5%-21.9pp

Returns & leverage

See full

Return on equity-28.2%-13.0pp

Debt / equity0.6×-0.2×

Current ratio2.7×-0.9×

Where this comes from

Reported directly by Arcutis Biotherapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:LongTermDebtNoncurrent.

The official record: Arcutis Biotherapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Arcutis Biotherapeutics, Inc.'s long-term debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Arcutis Biotherapeutics, Inc.'s long-term debt?: Arcutis Biotherapeutics, Inc. (ARQT) reported long-term debt of $101.47M in Q1 2026.
How has Arcutis Biotherapeutics, Inc.'s long-term debt changed year-over-year?: Arcutis Biotherapeutics, Inc.'s long-term debt decreased by 5.7% year-over-year, from $107.62M to $101.47M.
What does long-term debt mean?: Bonds, term loans, notes payable, and other borrowings with maturities beyond one year — the primary long-term financing source.